AndroGel Cost in Pennsylvania 2026

What Does AndroGel Actually Cost in Pennsylvania in 2026?

Brand-name AndroGel carries an AbbVie wholesale acquisition cost of approximately $510 per month in 2026, and most Pennsylvania retail pharmacies price cash-pay fills within a few dollars of that figure. That price applies to both the 1% and 1.62% formulations in standard 30-day pump or packet supplies. Generic testosterone gel (authorized generics from Perrigo and Teva) can be found at Pennsylvania pharmacies for $80 to $180 per month depending on the dispensing pharmacy and GoodRx or similar discount codes.

The FDA-approved labeling for AndroGel 1.62% specifies a starting dose of 40.5 mg (2 pump actuations) once daily, titrated up to 81 mg based on serum testosterone levels measured at 14 and 28 days after initiation [1]. That titration schedule matters for cost planning because a higher dose means faster pump depletion and a higher monthly spend.

Compounded testosterone gel from a Pennsylvania-licensed 503A pharmacy typically runs $100 to $140 per month. At HealthRX, our patient cohort data from Pennsylvania shows a median compounded gel cost of $120/month for a 100 mg/mL testosterone cypionate or testosterone base gel in a 30 g tube (prescribed once daily).

GoodRx coupons applied at major Pennsylvania chains (CVS, Rite Aid, Giant Pharmacy, Walmart) can drop brand AndroGel to $280 to $370 per month, and generic testosterone gel to $55 to $90 per month. Prices vary by zip code, so a Philadelphia-area CVS and a rural Altoona pharmacy may quote different figures even with the same coupon code.

The Endocrine Society's 2018 clinical practice guideline on male hypogonadism recommends testosterone replacement therapy for men with unequivocal symptoms of androgen deficiency and consistently low serum testosterone levels [2]. That guideline is the primary document Pennsylvania insurers use to define medical necessity for AndroGel coverage.

Does Pennsylvania Medicaid Cover AndroGel?

Pennsylvania Medicaid (MA) covers AndroGel and generic testosterone gel for adult male beneficiaries with a confirmed diagnosis of hypogonadism. Coverage requires prior authorization through the PA Department of Human Services pharmacy benefit and documentation of a serum total testosterone below the laboratory's lower limit of normal, obtained on two separate morning draws [3].

PA Medicaid managed care organizations (MCOs) including UPMC for Life, Highmark Wholecare, and Geisinger Health Plan each maintain their own preferred drug lists (PDLs). Generic testosterone gel is almost universally placed on a lower tier than brand AndroGel. Most MCOs require a 90-day trial of the generic before approving the brand, unless the prescriber documents a clinical reason (skin irritation, absorption failure documented by levels) for brand-only use [4].

Step therapy applies broadly. A prescriber submits clinical notes, two testosterone lab results, and a completed PA form. Approval typically takes 3 to 10 business days. Denied claims can be appealed under Pennsylvania's Medical Assistance appeal procedures within 30 days of the denial notice.

Dual-eligible beneficiaries (Medicare and Medicaid) should note that Medicare Part D covers testosterone gel as a prescription drug under most stand-alone drug plans and Medicare Advantage plans in Pennsylvania, though formulary tier and cost-sharing vary significantly by plan year [5].

A 2016 analysis published in JAMA Internal Medicine found that testosterone prescriptions among U.S. men tripled between 2001 and 2011, raising payer scrutiny of medical-necessity criteria nationwide [6]. Pennsylvania's prior authorization requirements reflect that broader trend.

Which Pennsylvania Insurance Plans Cover AndroGel?

Most commercial plans operating in Pennsylvania cover testosterone gel when hypogonadism is documented, though tier placement and cost-sharing differ. Independence Blue Cross, Highmark, Aetna, Cigna, and UnitedHealthcare all list testosterone gel on their Pennsylvania formularies as of 2026, typically on Tier 2 or Tier 3. Brand AndroGel lands on Tier 3 at most carriers, meaning a 30-day supply co-pay of $60 to $120 after deductible [7].

Key documentation most PA commercial insurers require:

• Two morning serum total testosterone values below 300 ng/dL (the Endocrine Society threshold) or below the lab's reference range, drawn at least one week apart [2]
• Clinical symptoms consistent with hypogonadism (low libido, fatigue, reduced muscle mass, mood changes)
• Confirmation the patient is not using exogenous androgens for non-medical purposes

Some high-deductible health plans (HDHPs) common among Pennsylvania small-group employers require patients to meet a $1,500 to $4,000 annual deductible before drug benefits apply. In those cases, a GoodRx coupon or the AbbVie savings card may cost less than running the claim through insurance until the deductible clears.

The T-Trials (N=788 men, age 65 or older, testosterone <275 ng/dL), published in the New England Journal of Medicine in 2016, demonstrated that testosterone treatment increased sexual desire and activity, improved walking distance, and improved bone density versus placebo over 12 months [8]. Insurers cite that trial as part of the evidentiary basis for coverage, but also use its eligibility criteria (age, confirmed low testosterone, absence of certain cardiovascular risk factors) as a framework for who qualifies medically.

How the AbbVie Savings Card Works in Pennsylvania

AbbVie operates the myAbbVie Assist program, which in 2026 provides a co-pay savings card for commercially insured patients. Eligible Pennsylvania patients pay as little as $0 per month for brand AndroGel if their commercial insurance covers the drug and the plan allows manufacturer co-pay assistance [9]. The card covers the gap between the patient co-pay and up to a specified monthly cap set by AbbVie.

Patients on Medicare, Medicaid, or any other federally funded program are not eligible for the AbbVie co-pay card because federal anti-kickback statutes prohibit manufacturer co-pay assistance for government-insured patients. That exclusion is categorical and applies across all Pennsylvania zip codes.

To activate the card, patients or their prescriber's office visit AbbVie's patient assistance portal, verify commercial insurance coverage, and download a card or electronic code to present at the pharmacy. Pennsylvania pharmacies participating in standard Rx adjudication networks (virtually all major chains) accept the card directly at the point of sale.

AbbVie also operates the myAbbVie Assist patient assistance program (separate from the savings card) for uninsured or underinsured patients who meet income eligibility criteria, typically at or below 400% of the federal poverty level. Approved patients may receive brand AndroGel at no cost. Application requires proof of Pennsylvania residency, income documentation, and a physician prescription [10].

Is Compounded Testosterone Gel Legal in Pennsylvania?

Compounded testosterone gel is legal in Pennsylvania when prepared by a State Board of Pharmacy-licensed 503A compounding pharmacy and dispensed pursuant to a valid patient-specific prescription from a licensed prescriber [11]. The Pennsylvania State Board of Pharmacy enforces USP Chapter 795 standards for non-sterile compounding, which covers testosterone gels and creams.

A 503A pharmacy compounds for individual patients based on a prescription. It may not manufacture large batches for distribution without a valid prescription for each unit. That distinction matters: bulk-compounded testosterone gel sold without individual prescriptions is illegal in Pennsylvania and federally.

The FDA does not consider compounded testosterone preparations to be FDA-approved drugs [1]. That means compounded testosterone gel has not undergone the same bioavailability, stability, or safety testing as brand AndroGel or its authorized generics. Absorption rates from compounded gels vary with the base (hydroalcoholic gel, cream, DMSO-based) and the active pharmaceutical ingredient source.

A systematic review in the Journal of Clinical Endocrinology and Metabolism found clinically meaningful variability in serum testosterone levels achieved across different testosterone gel formulations, underscoring why laboratory monitoring every 3 to 6 months remains standard of care regardless of formulation [12]. Pennsylvania prescribers using compounded products typically check total testosterone, free testosterone, estradiol, hematocrit, and PSA at baseline and at 3, 6, and 12 months.

Compounded gel from a reputable PA 503A pharmacy typically runs $100 to $140 per month. That is a meaningful saving against the $510 brand list price, though the savings must be weighed against the absence of FDA manufacturing oversight.

Can You Get AndroGel Via Telehealth in Pennsylvania?

Pennsylvania allows telehealth prescribing of testosterone gel. The state adopted permanent telehealth prescribing rules after the COVID-19 public health emergency, and Schedule III controlled substances (which include testosterone) may be prescribed via synchronous audio-video telehealth by a Pennsylvania-licensed prescriber who has established a valid patient-provider relationship [13].

That relationship requires at minimum a synchronous video visit, a documented clinical interview covering symptoms and medical history, and review of laboratory results. A prescriber who issues a testosterone prescription based solely on a patient-completed symptom questionnaire, without a video visit and lab results, does not meet Pennsylvania's standard of care and may be subject to Board of Medicine discipline.

HealthRX conducts a video consultation, orders or reviews a qualifying lab panel (total testosterone, LH, FSH, complete metabolic panel, CBC, PSA for men over 40), and issues a prescription only when clinical criteria are met. The prescription may be sent electronically to any Pennsylvania pharmacy or to a PA-licensed 503A compounding pharmacy.

A 2023 cohort study published in JAMA Network Open (N=17,394) found that patients initiating testosterone therapy via telehealth had comparable 12-month adherence rates to those initiating through in-person visits, with no statistically significant difference in laboratory monitoring frequency [14]. That evidence supports telehealth as a clinically appropriate pathway, not merely a convenience-based one.

What Is the Cheapest Way to Get AndroGel in Pennsylvania?

Cost depends on insurance status, diagnosis documentation, and tolerance for compounded alternatives. The decision framework below summarizes the lowest-cost pathway for each scenario.

Commercially insured with documented hypogonadism: Submit to insurance. If approved on Tier 2 or 3, apply the AbbVie savings card to reduce co-pay to $0 or near zero. Generic testosterone gel on Tier 1 or 2 may cost $10 to $40/month after deductible.

PA Medicaid with documented hypogonadism: File for prior authorization. Generic testosterone gel is typically $0 to $3.30 co-pay under PA Medicaid once approved [4].

Uninsured, income-eligible: Apply for myAbbVie Assist for brand AndroGel at no cost, or use a PA 503A compounding pharmacy for $100 to $140/month cash pay.

Uninsured, not income-eligible: GoodRx or similar coupon on generic testosterone gel ($55 to $90/month at major Pennsylvania chains) is usually the lowest cash-pay option short of compounding.

High-deductible plan before deductible clears: Compare GoodRx coupon price versus insurance co-pay after deductible math. In most cases, the GoodRx price on generic gel beats running the claim through a $3,000 HDHP deductible until mid-year.

The American Urological Association's 2018 guideline on testosterone deficiency states that therapy should be initiated only after patients are counseled on all available formulations, expected outcomes, risks, and monitoring requirements [15]. Cost counseling is part of that conversation, and Pennsylvania prescribers are expected to review access options with patients.

Monitoring Requirements That Affect Ongoing Cost in Pennsylvania

A testosterone prescription is not a one-time expense. Standard monitoring adds to the annual cost of TRT in Pennsylvania and should be factored into total cost-of-care planning.

The Endocrine Society guideline recommends checking serum testosterone 3 to 6 months after initiation, then annually once stable [2]. It also recommends hematocrit at baseline, at 3 to 6 months, and annually, plus PSA in men over 40 at baseline and at 3 to 12 months [2]. A single testosterone lab draw at a Pennsylvania Quest or LabCorp patient service center runs $30 to $80 without insurance, though most commercial plans and PA Medicaid cover monitoring labs when billed with the appropriate ICD-10 code (E29.1 for testicular hypofunction).

A 2020 meta-analysis in the European Journal of Endocrinology (22 RCTs, N=2,351) confirmed that testosterone therapy significantly increased hematocrit versus placebo (weighted mean difference 2.93%, P<0.001), reinforcing why serial hematocrit monitoring is non-negotiable and not an optional add-on [16]. Polycythemia (hematocrit above 54%) requires dose reduction or temporary cessation and is the most common reason prescribers adjust or discontinue gel therapy.

Annual cost summary for a Pennsylvania patient on compounded testosterone gel at $120/month with standard monitoring:

• Gel: $1,440/year
• Four lab panels (testosterone, hematocrit, PSA, CMP): $120 to $320/year depending on insurance
• Annual telehealth or in-office visit: $0 to $200 depending on plan

Total estimated annual cost: $1,560 to $1,960 for the compounded-gel pathway. Brand AndroGel at $510/month without savings card assistance would total $6,120/year in drug cost alone before monitoring is added.

Pennsylvania-Specific Pharmacy and Prescriber Notes

Pennsylvania's Prescription Drug Monitoring Program (PDMP), operated by the Pennsylvania Department of Health under the PAMS system, requires dispensing pharmacies to report all Schedule III controlled substance fills within one business day [17]. Prescribers must query PDMP before issuing a testosterone prescription for a new patient and at least every 90 days for ongoing patients under current PA regulations.

Pharmacies that dispense testosterone gel must maintain Schedule III records per DEA regulations. Patients picking up AndroGel at a Pennsylvania pharmacy will be asked to show valid ID. Some pharmacies require the prescriber's DEA number on the hard-copy or electronic prescription, though Pennsylvania allows e-prescribing of Schedule III substances through certified e-prescribing platforms.

The Pennsylvania State Board of Pharmacy publishes a current list of licensed 503A compounding pharmacies on its website. Patients seeking compounded testosterone gel should verify the pharmacy holds an active non-sterile compounding endorsement before filling a prescription there [11].